Dottikon ES Holding AG

Equities

DESN

CH0582581713

Pharmaceuticals

Market Closed - Swiss Exchange 12:30:28 2024-03-28 pm EDT 5-day change 1st Jan Change
238 CHF +0.42% Intraday chart for Dottikon ES Holding AG +0.42% +3.93%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Dottikon ES Posts Lower Fiscal H1 Net Income; Sales Up MT
Dottikon ES Holding AG Reports Earnings Results for the Half Year Ended September 30, 2023 CI
Dottikon ES Free Float Rises Amid Share Sale by Majority Investor MT
Dottikon ES' Majority Shareholder Kicks Off Share Sale MT
Dottikon ES Holding AG: Under the radar Our Logo
Dottikon ES Holding AG Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Dottikon ES Posts Higher FY23 Net Income; Net Sales Rise MT
Dottikon Es Holding AG Reports Earnings Results for the Half Year Ended September 30, 2022 CI
Swiss Chemicals Group Dottikon's Fiscal H1 Profit Jumps On Revaluation Of Deferred Tax Liabilities MT
Switzerland's Dottikon Forecasts Higher FY23 Sales Amid 31% Growth in Fiscal H1 MT
Swiss Chemicals Group Dottikon Unveils Additional Measures To Cut Energy Consumption MT
Global markets live: Credit Suisse, Telecom Italia, GSK, Apple, Boeing... Our Logo
Dottikon Es Holding AG Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Swiss Chemicals Group Dottikon's FY22 Profit Climbs 13% As Net Sales, Order Volume Grow MT
Certain Shares of Dottikon Es Holding AG are subject to a Lock-Up Agreement Ending on 14-DEC-2021. CI
Dottikon Es Holding AG Reports Earnings Results for the Half Year Ended September 30, 2021 CI
Dottikon ES Fiscal H1 Profit Rises 13% as Sales Grow MT
Dottikon Es Holding AG(SWX:DESN) added to S&P Global BMI Index CI
Dottikon Es Holding AG(SWX:DESN) added to Swiss Performance Index (Price Return) CI
Dottikon Es Holding Ag Reports Earnings Results for the Full Year Ended March 31, 2021 CI
Dottikon ES : Raises $214 Million Via Share Offering MT
Dottikon ES : Books Fully Covered in Share Offering MT
Dottikon ES : Core Shareholders Exercise Pre-Emptive Rights in Share Offering MT
Dottikon ES : Plans $244 Million Capital Raise to Finance Expansion MT
Dottikon ES Plans Capital Increase CI
Chart Dottikon ES Holding AG
More charts
Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The Company also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. It also held a 33.9%-stake in SYSTAG, System Technik AG.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
237
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Dottikon ES Holding AG - Swiss Exchange
  4. News Dottikon ES Holding AG
  5. Dottikon ES : CEO Plans to Retain Control With 72% Stake; Shares Jump 9%